CleanSpace Holdings Ltd (ASX:CSX)
A$ 0.40 (0%) Market Cap: 32.46 Mil Enterprise Value: 24.21 Mil PE Ratio: 17.17 PB Ratio: 1.46 GF Score: 27/100

Full Year 2025 Cleanspace Holdings Ltd Earnings Call Transcript

Aug 26, 2025 / 01:30AM GMT
Release Date Price: A$0.85 (+4.29%)

Key Points

Positve
  • CleanSpace Holdings Ltd (ASX:CSX) reported a 26% revenue growth to $19.8 million for FY25, marking the third consecutive year of growth.
  • The company achieved a significant improvement in gross margin, rising to 75%, driven by disciplined cost management and production efficiencies.
  • EBITDA turned positive in the second half of FY25, with a full-year EBITDA loss significantly reduced to $400,000 from $3.9 million in the previous year.
  • The company strengthened its cash position to $10.5 million, up from $9.8 million at the end of FY24, supported by positive operating cash flow and R&D tax incentives.
  • CleanSpace Holdings Ltd (ASX:CSX) successfully launched the CleanSpace Work respirator in the US market, expanding its product portfolio and geographic reach.
Negative
  • Despite improvements, the company still reported an EBITDA loss of $400,000 for the full year.
  • Operating expenses remained flat year-on-year, indicating limited reduction in cost structure despite revenue growth.
  • The company faced $700,000 in one-off costs, impacting overall profitability.
  • APAC sales were relatively low compared to Europe, despite being an Australian-based company.
  • The company is still in the early stages of development in Asia Pacific and other emerging markets, indicating potential challenges in market penetration.
Graham Mclean
Cleanspace Holdings Ltd - Chairman

Thank you very much, Darcy, and good morning, everybody, and welcome to the CleanSpace Holdings Limited annual results webinar for the year ending June 30, 2025, or FY25. My name is Graham McLean, and I'm the Chair of CleanSpace.

Joining me this morning are the CEO, Gabrielle O'Carroll; and the CFO, Bree Greeff. I will make a few introductory remarks and then hand over the meeting to Gabrielle to share the key results and highlights for the year. She and Bree will provide detailed information and perspectives on the company's performance during the 2025 financial year just concluded.

At the end of the presentation, there will be time for questions from the audience. Firstly, I would like to say on behalf of the Board that we are very pleased with the continuing progress of the business in FY25. Our strategy over the last three years has been clear and consistent. And during this time, it has developed more focus and delivered greater impact.

The growth in the revenue line every half year period over the last three years shows a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot